Skip to main content

Advertisement

Log in

Anticoagulant Therapy in Oncologic Patients Undergoing Venous Stenting for Superior Vena Cava Syndrome and Other Interventional Procedures

  • Letter to the Editor
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fagedet D, Thony F, Timsit JF et al (2013) Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol 36:140–149

    Article  PubMed  Google Scholar 

  2. Sofue K, Takeuchi Y, Arai Y, Sugimura K (2013) Life-threatening cerebral edema caused by acute occlusion of a superior vena cava stent. Cardiovasc Intervent Radiol 36:272–275

    Article  PubMed  Google Scholar 

  3. Lyman GH, Khorana AA, Falanga A et al (2007) American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25:5490–5505

    Article  CAS  PubMed  Google Scholar 

  4. Lyman GH, Khorana AA, Kuderer NM et al (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2189–2204

    Article  CAS  PubMed  Google Scholar 

  5. Akl EA, Labedi N, Barba M et al (2011) Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev 15(6):CD006650

    Google Scholar 

  6. Caine GJ, Stonelake PS, Lip GY, Kehoe ST (2002) The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 4:465–473

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Trousseau A (1865) Phlegmasia alba dolens. In: Clinique Medicale de l’Hotel—Dieu de Paris, vol 3, 2nd ed. Balliere, Paris, pp 654–712

  8. Green KB, Silverstein RL (1996) Hypercoagulability in cancer. Hematol Oncol Clin North Am 10:499–530

    Article  CAS  PubMed  Google Scholar 

  9. Gianni M, Norio P, Terao M et al (1995) Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells. Eur Cytokine Netw 6:157–165

    CAS  PubMed  Google Scholar 

  10. Kwaan HC, Keer HN (1990) Fibrinolysis and cancer. Semin Thromb Hemost 16:230–235

    Article  CAS  PubMed  Google Scholar 

  11. Marchetti M, Falanga A, Giovanelli S et al (1996) All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4. Br J Haematol 93:360–366

    Article  CAS  PubMed  Google Scholar 

  12. Gasic GJ, Stewart GJ (1984) Mechanisms of platelet aggregation by murine tumor cell shedding. In: Honn KV, Sloane BF (eds) Hemostatic mechanisms and metastases. Martinus Niijhoff, Boston, pp 127–138

    Chapter  Google Scholar 

  13. Rambaldi A, Alessio G, Casali B et al (1986) Induction of monocyte–macrophage procoagulant activity by transformed cell lines. J Immunol 136:3848–3855

    CAS  PubMed  Google Scholar 

  14. Semeraro N, Montemurro P, Conese M et al (1990) Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer 45:251–254

    Article  CAS  PubMed  Google Scholar 

  15. Mussoni L, Donati MB (1988) Expression of plasminogen activator as a marker of stimulation in tumor-associated macrophages. Haemostasis 18:66–71

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vittorio Iaccarino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iaccarino, V., Venetucci, P., Brunetti, A. et al. Anticoagulant Therapy in Oncologic Patients Undergoing Venous Stenting for Superior Vena Cava Syndrome and Other Interventional Procedures. Cardiovasc Intervent Radiol 37, 1401–1402 (2014). https://doi.org/10.1007/s00270-013-0791-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-013-0791-z

Keywords

Navigation